Management
Treatment of adult stem cells with TGF-beta increases the proportions and numbers of erythroid cells expressing fetal hemoglobin, suggesting a possible therapeutic role in beta-hemoglobin disorders like hemoglobin C beta thalassemia [PMID:14594506].
Prognosis & Follow-up
The reactivation of fetal hemoglobin by TGF-beta, similar to other therapeutic agents like aza-cytidine and sodium butyrate, might lead to better hematological parameters and reduced complications over follow-up periods [PMID:14594506].
Key Recommendations
Given the promising effects of TGF-beta in reactivating fetal hemoglobin expression, there is a need for clinical studies to assess its efficacy and safety in managing beta-hemoglobin disorders [PMID:14594506]. (Evidence: Moderate)
References
1 Böhmer RM. Reactivation of fetal hemoglobin in adult stem cell erythropoiesis by transforming growth factor-beta. Journal of hematotherapy & stem cell research 2003. link
1 papers cited of 3 indexed.